Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jasmeet Sidhu
Institution:
Tata Medical Center
Observed institutions:
University College of Medical Sciences,
Guru Teg Bahadur Hospital,
Dayanand Medical College & Hospital,
Tata Medical Center,
Hindu Rao Hospital,
University Children's Hospital Zurich
show all 6
ORCID:
0000-0001-5926-5167
Observed ORCID:
0000-0001-5926-5167
OpenAlex ID:
A5090567246
Works
31
Awards
1
Relapsed Acute Lymphoblastic Leukemia
2023
·
Jasmeet Sidhu
, Manash Pratim Gogoi
, et al.
·
The Indian Journal of Pediatrics
·
41
PDF
Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia
2021
·
Jasmeet Sidhu
, Manash Pratim Gogoi
, et al.
·
Pediatric Blood & Cancer
·
26
Acute Disseminated Encephalomyelitis After Plasmodium Vivax Infection: Case Report and Review of Literature
2015
·
Jasmeet Sidhu
, Anu Maheshwari
, et al.
·
Pediatric Reports
·
12
PDF
Activity and toxicity of intramuscular 1000 iu /m 2 polyethylene glycol‐ E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials
2022
·
Jasmeet Sidhu
, Ashish Narayan Masurekar
, et al.
·
British Journal of Haematology
·
8
PDF
Maternal and Neonatal Tetanus: A Journey into Oblivion.
2016
·
Jasmeet Sidhu
, Pooja Dewan
, et al.
·
PubMed
·
7
Therapeutic drug monitoring informs asparaginase dose scheduling in the InPOG-ALL-15-01-ICiCLe-ALL-14 trial
2017
·
Jasmeet Sidhu
, Debparna Saha
, et al.
·
Pediatric Hematology Oncology Journal
·
2
Functional precision approach in patients with very high risk acute lymphoblastic leukaemia in India: a single-centre cohort study
2026
·
Jasmeet Sidhu
, Arijit Chakraborty
, et al.
·
The Lancet Regional Health - Southeast Asia
·
1
Delayed Intensification Including Venetoclax and Bortezomib Prolongs Survival in Very High Risk Acute Lymphoblastic Leukaemia
2023
·
Jasmeet Sidhu
, Arijit Chakraborty
, et al.
·
Blood
·
1
Phenotypic Drug Response Profiling Identifies Asparaginase-Based Synergistic Combinations for Very High Risk Acute Lymphoblastic Leukaemia
2023
·
Jasmeet Sidhu
, Fabio D. Steffen
, et al.
·
Blood
·
1
PDF
MSC.sensor: Capturing cancer cell interactions with stroma for functional profiling
2023
·
Yun Huang
, Aneta Drakul
, et al.
·
SLAS DISCOVERY
·
1
PDF
Systematic clinical and pharmacological monitoring of a PEG-asparaginase biogeneric (HAMSYL) in paediatric patients with newly-diagnosed acute lymphoblastic leukaemia
2023
·
Duhita Sengupta
, Bishwaranjan Jana
, et al.
·
Pediatric Hematology Oncology Journal
·
1
Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia
2022
·
Jasmeet Sidhu
, Shruti Banerjee
, et al.
·
Pediatric Hematology Oncology Journal
·
1
PDF
Reply to: Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India—Implications for clinical outcomes in acute lymphoblastic leukaemia
2021
·
Jasmeet Sidhu
, Vaskar Saha
, et al.
·
Pediatric Blood & Cancer
·
1
A simple clinical score to predict outcome in hospitalized extramural neonates
2015
·
Jasmeet Sidhu
, Harmesh Bains
·
International Journal of Contemporary Pediatrics
·
1
PDF
Biogeneric Native and Polyethylene Glycol–conjugated Escherichia coli Asparaginases for Treating Children with Acute Lymphoblastic Leukemia
2026
·
Neerajana Datta
, Bishwaranjan Jana
, et al.
·
Therapeutic Drug Monitoring
End-of-Life Care in Paediatric Cancer: A Retrospective Single-Centre Analysis from North India
2026
·
Sanjukta Mukhopadhyay
, Vijeta Sharma
, et al.
·
Pediatric Hematology Oncology Journal
PDF
Determinants of Health-Related Quality of Life in Children with Bone Sarcoma: A Multidimensional Patient-Reported Outcome Study from North India
2026
·
Sanjukta Mukhopadhyay
, Sakshi Chauhan
, et al.
·
Pediatric Hematology Oncology Journal
PDF
Lineage-specific differences in clinical characteristics, genetics, and minimal residual disease clearance in pediatric acute lymphoblastic leukemia
2026
·
Jasmeet Sidhu
, Ravikiran Pawar
, et al.
·
Pediatric Hematology Oncology Journal
PDF
Central venous access in Paediatric Oncology at a tertiary care cancer care centre in North India: device selection, CLABSI burden and multidrug-resistant gram-negative antibiogram
2026
·
Varsha Mishra Sopori
, Bhagwan Bardwal
, et al.
·
Pediatric Hematology Oncology Journal
PDF
Clinical Profile, Demographics, and Early Outcomes of a Paediatric Oncology Cohort at a Newly Established Tertiary Care Cancer Centre in Northern India
2026
·
Abhishek Sharma
, Vijeta Sharma
, et al.
·
Pediatric Hematology Oncology Journal
PDF
Pre-Treatment cHIPS score Predicts Early Metabolic Response on Interim PET in Paediatric Classic Hodgkin Lymphoma: A Single-Centre Study from North India
2026
·
Sanjukta Mukhopadhyay
, Jasmeet Sidhu
, et al.
·
Pediatric Hematology Oncology Journal
PDF
Determinants of Health-Related Quality of Life in Children with Bone Sarcoma: A Multidimensional Patient-Reported Outcome Study from North India
2026
·
Sanjukta Mukhopadhyay
, Vijeta Sharma
, et al.
·
Pediatric Hematology Oncology Journal
PDF
Clinical and pharmacological monitoring of Asviia, a biogeneric polyethylene glycol-conjugated E. coli asparaginase
2024
·
Bishwaranjan Jana
, Bony Dasgupta
, et al.
·
Pediatric Hematology Oncology Journal
Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials
2022
·
Jasmeet Sidhu
, Ashish Narayan Masurekar
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
Unique mutation and gene expression in High Hyperdiploid Acute Lymphoblastic Leukaemia with whole chromosome uniparental isodisomy
2022
·
Mayur Parihar
, Debdutta Ganguli
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
31
Citation count:
104
H-index:
5
I10-index:
3
Year
Topic
Type